{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T16:03:31Z","timestamp":1709568211482},"reference-count":0,"publisher":"Ecancer Global Foundation","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ecancer"],"published-print":{"date-parts":[[2009,1,1]]},"DOI":"10.3332\/ecancer.2008.111","type":"journal-article","created":{"date-parts":[[2009,1,30]],"date-time":"2009-01-30T10:07:38Z","timestamp":1233310058000},"source":"Crossref","is-referenced-by-count":3,"title":["Pegylated Liposomal Doxorubicin (PLD): Enhanced skin toxicity in areas of vitiligo"],"prefix":"10.3332","volume":"3","author":[{"given":"Y","family":"Yuan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1871","container-title":["ecancermedicalscience"],"original-title":[],"link":[{"URL":"http:\/\/ecancer.org\/journal\/2\/pdf\/111-pegylated-liposomal-doxorubicin-pld-enhanced-skin-toxicity-in-areas-of-vitiligo.php","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,12,8]],"date-time":"2016-12-08T09:54:02Z","timestamp":1481190842000},"score":1,"resource":{"primary":{"URL":"http:\/\/ecancer.org\/ecms\/2\/111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,1]]},"references-count":0,"URL":"https:\/\/doi.org\/10.3332\/ecancer.2008.111","relation":{},"ISSN":["1754-6605"],"issn-type":[{"value":"1754-6605","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,1]]}}}